Status:
UNKNOWN
Proviral DNA as a Target for HIV-1 Resistance Analysis
Lead Sponsor:
University of Chile
Collaborating Sponsors:
ViiV Healthcare
Conditions:
HIV/AIDS
HIV Infections
Eligibility:
All Genders
18-99 years
Brief Summary
In summary, in this project the investigators propose to study the proviral DNA genotyping to implement a lower cost and wider than the commercial systems currently in use, in order to analyze all HIV...
Detailed Description
A prospective longitudinal observational study, the objective is to observe and describe the prevalence of INRT, INNRT, Protease and INIS mutations detected by proviral DNA in patients with virologic ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of HIV
- viral load \<1.000 copies/mL
- under antiretroviral tratment
Exclusion
- HIV negative
- viral load \>1.000 copies/mL
Key Trial Info
Start Date :
October 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04088916
Start Date
October 15 2018
End Date
December 31 2022
Last Update
September 17 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Immunology, HIV and Allergy Section
Santiago, Santiago Metropolitan, Chile
2
Molecular Medicine Laboratory
Santiago, Santiago Metropolitan, Chile